Does Venous pCO2 Increase by 20 mmHg or More During Apnea Challenge Test?
1 other identifier
interventional
7
1 country
1
Brief Summary
One required examination for declaration of death by neurological criteria is the apnea challenge test. The apnea challenge test evaluates the medulla brainstem respiratory center response to a rise in CO2. The current guideline requires arterial sampling of CO2 and therefore either arterial puncture or arterial catheter placement for the examination. Arterial catheter is an invasive monitoring device and is not without complications. Recent studies have demonstrated that there is a direct correlation between peripheral venous and arterial blood gas measures and that peripheral venous CO2 measures may be used as alternatives to arterial CO2 measure.The purpose of this study is to evaluate brainstem response during the apnea challenge test to a rise in venous CO2 and correlate it with the rise in arterial measured CO2. The objective of this study is to demonstrate a similar rise between the venous and arterial CO2 during the apnea challenge test and eliminate the necessity of arterial blood sampling for the sole purpose of apnea challenge test in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 16, 2015
CompletedFirst Posted
Study publicly available on registry
July 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedOctober 3, 2022
July 1, 2015
2.2 years
July 16, 2015
September 29, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in venous blood CO2 during apnea challenge test
During apnea challenge test
Secondary Outcomes (1)
Change in End Tidal CO2 during apnea challenge test
During apnea challenge test
Study Arms (1)
Experimental
EXPERIMENTALVenous blood gas will be obtained at the same time points as arterial blood gas in the apnea challenge test.
Interventions
Venous blood gas will be measured at the time of arterial blood gas measurement.
Eligibility Criteria
You may qualify if:
- Age \> 37 weeks gestation up to any adult age
- Patients admitted to Pediatric Intensive Care unit (PICU), Neonatal Intensive Care Unit (NICU), Medical Intensive Care Unit (MICU) and Cardiothoracic Intensive Care Unit (CTICU)
- Patients with irreversible brain injury where the attending physician will be performing death by neurological criteria examination as per hospital policy
- Presence of arterial catheter or arterial blood sampling during apnea challenge test
- Presence of central venous catheter or easily drawing peripheral intravenous catheter
You may not qualify if:
- Age less or equal to 37 weeks gestation
- Inability to perform apnea challenge test as determined by primary physician
- Family request for Donation after Cardiac Death (DCD) or withdrawal of Life Sustaining Therapy
- Bicarbonate infusion within 30 minutes of apnea challenge test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Long Beach Memorial and Miller Children's & Women's Hospital Long Beach
Long Beach, California, 90806, United States
Related Publications (1)
Fathi A, Lake JL. Use of Venous Pco2 in Determination of Death by Neurological Criteria in Children. Pediatr Neurol. 2019 Apr;93:17-20. doi: 10.1016/j.pediatrneurol.2018.12.001. Epub 2018 Dec 19.
PMID: 30704867RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Critical Care Transport, Assoicate Medical Director, PICU
Study Record Dates
First Submitted
July 16, 2015
First Posted
July 21, 2015
Study Start
July 1, 2015
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
October 3, 2022
Record last verified: 2015-07